Trident Lifeline Annual General Meeting
Trident Lifeline Ltd conducted its 13th Annual General Meeting on September 26, 2026, to approve financial statements, director re-appointment, and managerial remuneration proposals.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements with these filters
Trident Lifeline Ltd conducted its 13th Annual General Meeting on September 26, 2026, to approve financial statements, director re-appointment, and managerial remuneration proposals.
Trident Lifeline Limited clarified to the stock exchange that recent share price movements are purely market-driven, confirming no pending undisclosed material information.
Trident Lifeline Limited received an award from PHARMEXCIL for its contribution to India's pharmaceutical exports. This recognition highlights the company's growth in global markets.
Trident Lifeline Limited has scheduled its 13th Annual General Meeting for September 26, 2026. The company concurrently released its Annual Report for the financial year 2025-26.
Trident Lifeline Ltd has revised its Book Closure dates and e-voting Cut-off date for the 13th Annual General Meeting. New Book Closure begins September 20, 2026.
Trident Lifeline Limited allotted 24,000 equity shares upon conversion of warrants at ₹266 per share. This exercise increased the company's paid-up share capital.
Trident Lifeline allotted 24,000 equity shares upon the conversion of 24,000 warrants, aggregating Rs. 0.48 Crore. This allotment changes the company's paid-up equity share capital.
Trident Lifeline Ltd has been selected for the 'Outstanding Contribution to India's Pharmaceutical Exports' award by PHARMEXCIL. The award ceremony is scheduled for September 7, 2026.
Trident Lifeline Limited approved the Board’s Report for FY 2026 and the draft notice for its 13th AGM scheduled for September 26, 2026.
Trident Lifeline Limited announced it was featured in India Pharma Outlook magazine. The feature highlights the company's growth, business strengths, and strategic initiatives.
Trident Lifeline Limited has been selected for the 'Fastest Growing SMEs' award by India SME Forum and Axis Bank in the Top 50 SME Awards - Gujarat.
Trident Lifeline (TLL) achieved ₹129 Cr consolidated revenue in FY26, a 48% increase. Strategy centers on a demand-led manufacturing model and aggressive global registration expansion.
Trident Lifeline Ltd reported revenue from operations of ₹33.7 Cr (+42.8% YoY) and net profit of ₹5 Cr (+61.3% YoY) for Q1 FY27.
Trident Lifeline Ltd scheduled a Board Meeting for July 29, 2026. The meeting will consider the unaudited financial results for the June 30, 2026 quarter.
Trident Lifeline shareholders approved migrating from BSE SME to the Main Board of BSE and NSE. They also confirmed appointing two Independent Directors via postal ballot.
Trident Lifeline shareholders approved the migration from BSE SME platform to the Main Boards of BSE and NSE. The resolution was passed via postal ballot with majority support.